Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Bomke

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Pharmacology|November 18, 2022
Differences in Sustained Cellular Effects of MET inhibitors Are Driven by Prolonged Target Engagement and Lysosomal RetentionNina Berges, Jan Henrik Klug, Anna Eicher, et al.
Analytical Biochemistry|November 17, 2011
In-depth biophysical analysis of interactions between therapeutic antibodies and the extracellular domain of the epidermal growth factor receptorMaria Leonor Alvarenga, Judith Kikhney, Jens Hannewald, et al.
Biochemistry|June 11, 2009
Identification and characterization of novel small molecules as potent inhibitors of the plasmodial calcium-dependent protein kinase 1Guillaume Lemercier, Amaury Fernandez-Montalvan, Jeffrey P Shaw, et al.
Communications Chemistry|December 22, 2025
Pushing the limits of hydrogen/deuterium exchange mass spectrometry to study protein:fragment low affinity interactionsCatarina F Malta, Diana O Silva, Ulrich Grädler, et al.
Plos One|November 23, 2013
Functional analysis of Hsp70 inhibitorsRainer Schlecht, Sebastian R Scholz, Heike Dahmen, et al.
Journal of Chemical Theory and Computation|May 18, 2018
Estimation of Drug-Target Residence Times by τ-Random Acceleration Molecular Dynamics SimulationsDaria B Kokh, Marta Amaral, Joerg Bomke, et al.
Cell Chemical Biology|January 26, 2021
Structure-kinetic relationship reveals the mechanism of selectivity of FAK inhibitors over PYK2Benedict-Tilman Berger, Marta Amaral, Daria B Kokh, et al.
Journal of Medicinal Chemistry|December 20, 2024
MoA Studies of the TEAD P-Site Binding Ligand MSC-4106 and Its Optimization to TEAD1-Selective Amide M3686Timo Heinrich, Daniel Schwarz, Carl Petersson, et al.
Nucleic Acids Research|December 8, 2025
Mechanistic insights into the monotherapy and combination potential of FEN1 inhibition in cancer therapyEeson Rajendra, Claudio A Lademann, Bethany Mason, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Pharmacology|November 18, 2022
Differences in Sustained Cellular Effects of MET inhibitors Are Driven by Prolonged Target Engagement and Lysosomal RetentionNina Berges, Jan Henrik Klug, Anna Eicher, et al.
Analytical Biochemistry|November 17, 2011
In-depth biophysical analysis of interactions between therapeutic antibodies and the extracellular domain of the epidermal growth factor receptorMaria Leonor Alvarenga, Judith Kikhney, Jens Hannewald, et al.
Biochemistry|June 11, 2009
Identification and characterization of novel small molecules as potent inhibitors of the plasmodial calcium-dependent protein kinase 1Guillaume Lemercier, Amaury Fernandez-Montalvan, Jeffrey P Shaw, et al.
Communications Chemistry|December 22, 2025
Pushing the limits of hydrogen/deuterium exchange mass spectrometry to study protein:fragment low affinity interactionsCatarina F Malta, Diana O Silva, Ulrich Grädler, et al.
Plos One|November 23, 2013
Functional analysis of Hsp70 inhibitorsRainer Schlecht, Sebastian R Scholz, Heike Dahmen, et al.
Journal of Chemical Theory and Computation|May 18, 2018
Estimation of Drug-Target Residence Times by τ-Random Acceleration Molecular Dynamics SimulationsDaria B Kokh, Marta Amaral, Joerg Bomke, et al.
Cell Chemical Biology|January 26, 2021
Structure-kinetic relationship reveals the mechanism of selectivity of FAK inhibitors over PYK2Benedict-Tilman Berger, Marta Amaral, Daria B Kokh, et al.
Journal of Medicinal Chemistry|December 20, 2024
MoA Studies of the TEAD P-Site Binding Ligand MSC-4106 and Its Optimization to TEAD1-Selective Amide M3686Timo Heinrich, Daniel Schwarz, Carl Petersson, et al.
Nucleic Acids Research|December 8, 2025
Mechanistic insights into the monotherapy and combination potential of FEN1 inhibition in cancer therapyEeson Rajendra, Claudio A Lademann, Bethany Mason, et al.
Pageof 1